Table 3 Clinical characteristics of COPD patients complicated with ABPA
| Â | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 |
|---|---|---|---|---|---|---|---|---|
Gender | Male | Female | Male | Male | Female | Female | Male | Male |
Age (yr) | 78 | 73 | 81 | 57 | 73 | 80 | 54 | 67 |
Chronic cough/sputum history (yr) | 30 | 30 | 25 | 8 | 30 | 20 | 3 | 27 |
Dyspnea history (yr) | 10 | 20 | 15 | 5 | 15 | 15 | 3 | 20 |
Ratio of dyspnea history to chronic cough/sputum history | 0.33 | 0.67 | 0.60 | 0.63 | 0.50 | 0.75 | 1.00 | 0.74 |
Occurrence of wheezing | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Eosinophil of peripheral blood (%) | 11.7 | 8.6 | 7.5 | 8.0 | 5.1 | 5.0 | 16.3 | 5.5 |
Serum T-IgE (kU/L) | 7420 | 1239 | 5000 | 2049 | 1187 | 2272 | 1279 | 1160 |
Serum aspergillus specific IgE (kUA/L) | 4.89 | 62.3 | 6.91 | 2.07 | 3.58 | 2.30 | 22 | 0.70 |
Serum aspergillus specific IgG (mg/L) | 121 | ND | 102 | ND | ND | 92 | ND | 68 |
SPT (grade) | (++) | (+++) | (++) | (++) | (++++) | (++) | (++) | (++) |
Chest HRCT | Â | Â | Â | Â | Â | Â | Â | Â |
Central bronchiectasis | Yes | No | Yes | No | Yes | Yes | Yes | No |
Mucoid impaction | No | No | Yes | No | No | No | No | No |
Pulmonary opacities | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Lung function (postbronchodilator) | Â | Â | Â | Â | Â | Â | Â | Â |
FEV1/FVC(%) | 31 | 30 | 30 | 23 | 35 | 67 | 42 | 42 |
FEV1%predicted | 35 | 26 | 25 | 14 | 39 | 36 | 30 | 23 |
Type of ABPA | CB | S | CB | S | CB | CB | CB | S |